LifeMD Preferred Valuation
| LFMDP Preferred Stock | USD 23.80 0.40 1.71% |
At this time, the firm appears to be overvalued. LifeMD Preferred Series secures a last-minute Real Value of $19.82 per share. The latest price of the firm is $23.8. Our model forecasts the value of LifeMD Preferred Series from analyzing the firm fundamentals such as Profit Margin of (0.44) %, return on equity of -44.07, and Current Valuation of 638.22 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that LifeMD Preferred's price fluctuation is very steady at this time. Calculation of the real value of LifeMD Preferred Series is based on 3 months time horizon. Increasing LifeMD Preferred's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
LifeMD Preferred's intrinsic value may or may not be the same as its current market price of 23.80, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.8 | Real 19.82 | Hype 23.8 | Naive 23.41 |
The intrinsic value of LifeMD Preferred's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LifeMD Preferred's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of LifeMD Preferred Series helps investors to forecast how LifeMD preferred stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LifeMD Preferred more accurately as focusing exclusively on LifeMD Preferred's fundamentals will not take into account other important factors: LifeMD Preferred Total Value Analysis
LifeMD Preferred Series is now forecasted to have takeover price of 638.22 M with market capitalization of 638.22 M, debt of 1.41 M, and cash on hands of 5.84 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the LifeMD Preferred fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
638.22 M | 638.22 M | 1.41 M | 5.84 M |
LifeMD Preferred Investor Information
The company recorded a loss per share of 2.26. LifeMD Preferred Series last dividend was issued on the 5th of January 2023. Based on the measurements of operating efficiency obtained from LifeMD Preferred's historical financial statements, LifeMD Preferred Series is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in August.LifeMD Preferred Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. LifeMD Preferred has an asset utilization ratio of 186.04 percent. This connotes that the Company is making $1.86 for each dollar of assets. An increasing asset utilization means that LifeMD Preferred Series is more efficient with each dollar of assets it utilizes for everyday operations.LifeMD Preferred Profitability Analysis
The company reported the revenue of 92.88 M. Net Loss for the year was (60.9 M) with profit before overhead, payroll, taxes, and interest of 74.88 M.About LifeMD Preferred Valuation
The preferred stock valuation mechanism determines LifeMD Preferred's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of LifeMD Preferred Series based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of LifeMD Preferred. We calculate exposure to LifeMD Preferred's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LifeMD Preferred's related companies.LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. Lifemd Inc operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.
8 Steps to conduct LifeMD Preferred's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates LifeMD Preferred's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct LifeMD Preferred's valuation analysis, follow these 8 steps:- Gather financial information: Obtain LifeMD Preferred's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine LifeMD Preferred's revenue streams: Identify LifeMD Preferred's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research LifeMD Preferred's industry and market trends, including the size of the market, growth rate, and competition.
- Establish LifeMD Preferred's growth potential: Evaluate LifeMD Preferred's management, business model, and growth potential.
- Determine LifeMD Preferred's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate LifeMD Preferred's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
LifeMD Preferred Growth Indicators
Investing in growth stocks can be very risky. If the company such as LifeMD Preferred does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 30.6 M | |
| Retained Earnings | -141.9 M |
Additional Tools for LifeMD Preferred Stock Analysis
When running LifeMD Preferred's price analysis, check to measure LifeMD Preferred's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD Preferred is operating at the current time. Most of LifeMD Preferred's value examination focuses on studying past and present price action to predict the probability of LifeMD Preferred's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD Preferred's price. Additionally, you may evaluate how the addition of LifeMD Preferred to your portfolios can decrease your overall portfolio volatility.